BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
96 hedge funds and large institutions have $189M invested in Bellicum Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 46 increasing their positions, 13 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
+6
Holders Change %
+6.67%
% of All Funds
2.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
46
Reduced
13
Closed
14
Calls
$654K
Puts
$1.35M
Net Calls
-$695K
Net Calls Change
-$29K
Top Buyers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$14.8M |
| 2 |
FM
Frazier Management
Seattle,
Washington
|
+$7.76M |
| 3 |
BlackRock
New York
|
+$6.27M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$6.2M |
| 5 |
JPMorgan Chase & Co
New York
|
+$5.24M |
Top Sellers
| 1 |
AC
Ascend Capital
Orinda,
California
|
-$2.63M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$2.3M |
| 3 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$1.84M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.06M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$696K |
